Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
DSS ( (DSS) ) has issued an announcement.
On July 21, 2025, DSS, Inc. entered into a Debt Conversion Agreement with Impact Biomedical Inc. to settle a $12 million revolving promissory note originally issued in March 2023. This agreement involved DSS receiving 31,939,778 shares of Impact’s common stock, fully satisfying all outstanding debts and obligations owed by Impact to DSS, potentially impacting DSS’s financial position and stakeholder interests.
More about DSS
Average Trading Volume: 85,577
Technical Sentiment Signal: Sell
Current Market Cap: $10.55M
For a thorough assessment of DSS stock, go to TipRanks’ Stock Analysis page.